Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

109-120 of 163 results
Page 10 of 14
Key Publications October 12, 2017

Effect of long-term metformin and lifestyle in the Diabetes Prevention Program and its Outcome Study on coronary artery calcium.

Circulation. 2017 4;136:52-64

Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff M, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M, Diabetes Prevention Program Research Group
Cardiovascular Disease Clinical Cardiology Insulin Resistance
Expert Opinions September 13, 2017

Could you describe the possibly deleterious impact of excessive amount of exercise on the heart and the cardiovascular system?

Carl J. Lavie, MD, FACC, FACP, FCCP, Professor of Medicine and Medical Director, Cardiac Rehabilitation and Preventive Cardiology; Director, Exercise Testing Laboratory; and Staff Cardiologist, Echocardiographic Laboratory at the John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA, United States
Cardiovascular Disease Clinical Cardiology Physical Activity/Exercise
Key Publications July 20, 2017

Body mass index, carotid plaque, and clinical outcomes in patients with coronary artery disease.

Coron Artery Dis. 2017;28:278-286

Park HW, Kim KH, Song IG, Kwon TG, Kim WH, Bae JH
Cardiovascular Disease Clinical Cardiology Obesity
Key Publications July 10, 2017

Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with 18F-NaF PET-CT.

Atherosclerosis. 2017;260:41-46

Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, Donato P, Pedroso de Lima J, Pego M, Gonçalves L, Ferreira MJ
Cardiovascular Disease Clinical Cardiology Ectopic Fat
Key Publications June 22, 2017

Relation of epicardial adipose tissue radiodensity to coronary artery calcium on cardiac computed tomography in patients at high risk for cardiovascular disease.

Am J Cardiol. 2017;119:1359-1365

Franssens BT, Nathoe HM, Visseren FL, van der Graaf Y, Leiner T, SMART Study Group
Cardiovascular Disease Clinical Cardiology Ectopic Fat
Key Publications June 22, 2017

Relation of fasting triglyceride-rich lipoprotein cholesterol to coronary artery calcium score (from the ELSA-Brasil Study).

Am J Cardiol. 2017;119:1352-1358

Bittencourt MS, Santos RD, Staniak H, Sharovsky R, Kondapally R, Vallejo-Vaz AJ, Ray KK, Bensenor I, Lotufo P
Cardiovascular Disease Clinical Cardiology Lipids/Lipoproteins
Key Publications April 18, 2017

Importance of assessing cardiorespiratory fitness in clinical practice: A case for fitness as a clinical vital sign: A scientific statement from the American Heart Association.

Circulation. 2016;134:e653-e699

Ross R, Blair SN, Arena R, Church TS, Després JP, Franklin BA, Haskell WL, Kaminsky LA et al.
Cardiovascular Disease Clinical Cardiology Physical Activity/Exercise
Key Publications April 6, 2017

Progression of CAC score and risk of incident CVD.

JACC Cardiovasc Imaging. 2016;9:1420-1429

Radford NB, DeFina LF, Barlow CE, Lakoski SG, Leonard D, Paixao AR, Khera A, Levine BD
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications April 6, 2017

Temporal change in CAC score and prognosis: Follow-up score is simpler and as good as a change in score.

JACC Cardiovasc Imaging. 2016;9:1430-1431

Shah PK
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications March 29, 2017

The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography.

J Am Coll Cardiol. 2016;68:2467-2478

Arbab-Zadeh A, Fuster V
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications March 28, 2017

Effect on fasting serum glucose levels of adding ezetimibe to statins in patients with nondiabetic hypercholesterolemia.

Am J Cardiol. 2016;118:1812-1820

Toth PP, Catapano AL, Farnier M, Foody J, Tomassini JE, Jensen E, Polis AB, Hanson ME, Musliner TA, Tershakovec AM
Clinical Cardiology Insulin Resistance Lipids/Lipoproteins
Key Publications March 28, 2017

Safety of alirocumab (a PCSK9 monoclonal antibody) from 14 randomized trials.

Am J Cardiol. 2016;118:1805-1811

Jones PH, Bays HE, Chaudhari U, Pordy R, Lorenzato C, Miller K, Robinson JG
Clinical Cardiology Clinical Trials Lipids/Lipoproteins
of 14